Edward Cordasco, DO
Pulmonary Disease · Columbus, OHNPI 1164428090
Payments from drug & device makers
Across 1,074 payments — averaging $7413.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$3.3M
- Ironwood Pharmaceuticals, Inc$678K
- Modernatx, Inc.$619K
- AstraZeneca$600K
- Mitsubishi Tanabe Pharma Development America, Inc.$539K
- Tanabe Pharma America, Inc.$484K
- plus $1.8M from 12 others
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 145 | $3,289,991 |
| Ironwood Pharmaceuticals, Inc | 76 | $678,145 |
| Modernatx, Inc. | 68 | $619,268 |
| AstraZeneca | 26 | $599,721 |
| Mitsubishi Tanabe Pharma Development America, Inc. | 9 | $539,149 |
| Tanabe Pharma America, Inc. | 211 | $483,871 |
| Janssen Research & Development, LLC | 132 | $391,815 |
| Applied Therapeutics, Inc. | 78 | $306,816 |
| Pfizer | 135 | $277,415 |
| GSK | 13 | $189,013 |
| Merck | 56 | $125,087 |
| Hikma Pharmaceuticals USA | 8 | $123,386 |
| Braintree Laboratories, Inc. | 21 | $122,379 |
| Sanofi US Services Inc. | 35 | $121,757 |
| Medline Industries LP | 12 | $30,341 |
| Boehringer Ingelheim | 8 | $29,116 |
| Boehringer Ingelheim Canada Ltd.ltee | 36 | $27,858 |
| Incyte Corporation | 5 | $6,815 |
How this compares
$7,961,943 in reported general payments places this provider in the 95th percentile of 571 pulmonary disease providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Columbus
- Brian ZenoColumbus$2.9M
- Roy St JohnColumbus$1.9M
- Nitin BhattColumbus$876K
- Matthew ExlineColumbus$386K
- Christian GhattasColumbus$286K
- Alberto ReveloColumbus$232K
- Derrick HermanColumbus$213K
- James FaganColumbus$179K
- Todd AstorColumbus$102K
- Lynn FussnerColumbus$76K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.